{"id":"https://genegraph.clinicalgenome.org/r/ba5b2b2d-d833-4fab-a344-ff2ddced5d33v1.0","type":"EvidenceStrengthAssertion","dc:description":"CHCHD10 codes for the coiled-coil-helix-coiled-coil-helix domain containing 10 protein, a mitochondrial protein that is involved in oxidative phosphorylation and cristae morphology maintenance. CHCHD10 has been reported to cause ALS-FTD, mitochondrial myopathy, and late onset spinal muscular atrophy (Jokela type). Mitochondrial myopathy was determined to be an independent disease entity and was spilt from the CHCHD10 curation; however, evidence related to ALS, ALS/FTD, FTD, and late onset spinal muscular atrophy were considered. CHCHD10 was first reported to be responsible for autosomal dominant ALS-FTD in a large, five-generation family of French ancestry through exome sequencing and segregation analysis within the family. At least 17 variants in the CHCHD10 gene have since been reported to cause ALS-FTD in humans of diverse geoancestry across several publications (PMID: 24934289, 25726362, 25113787, 25261972, 25576308, 25155093, 25681414, 25833818, 26152333, 29789341, 26719383, 27056076). However, several reported variants have relatively high minor allele frequencies in population databases (>0.000005 in gnomAD) and were not scored as genetic-level evidence. Notably, the R15L variant in CHCHD10 was consistently reported to cause ALS-FTD across several populations and has functional evidence to support its disruption of mitochondrial function (PMID: 29121267). There is one variant in CHCHD10 that has been reported to cause late onset spinal muscular atrophy (Jokela type) in several families of Finnish ancestry (Gly66Val). This variant was not scored due to high frequency in population databases in the European Finnish population specifically (0.0001891 in gnomAD) (PMID: 21715705, 27810918). \n\nOverall evidence supporting the CHCHD10 gene-disease relationship includes case-level data and experimental data. Postmortem analysis of a patient with CHCHD10 ALS (R15L) identified numerous aggregates of CHCHD10 within the anterior horns (PMID: 32042922). A knock-in mouse study (R15L) demonstrated that mutant mice develop progressive motor deficits, abnormal morphology and innervation of the neuromuscular junction, and accelerated mortality (PMID: 30877432). Protein interaction studies have demonstrated that CHCHD10 mutations induce cytoplasmic TDP-43 mis localization, potentiate TDP-43-induced apoptosis and synaptic impairment, and induce insoluble TDP-43 and (PMID: 28585542, 33772006). \n\nIn summary, there is moderate evidence to support a gene-disease relationship between CHCHD10 and frontotemporal dementia and/or amyotrophic lateral sclerosis 2. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen ALS GCEP on the meeting date September 13, 2022 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/ba5b2b2d-d833-4fab-a344-ff2ddced5d33","GCISnapshot":"https://genegraph.clinicalgenome.org/r/d154f67a-25ce-40d3-9de3-1f001753843a","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/d154f67a-25ce-40d3-9de3-1f001753843a_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10096","date":"2022-09-13T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/d154f67a-25ce-40d3-9de3-1f001753843a_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10096","date":"2022-12-20T21:29:24.900Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d154f67a-25ce-40d3-9de3-1f001753843a_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0e59889-74b5-4817-bf1d-9bd0c3147b04","type":"EvidenceLine","dc:description":"Variant absent from gnomAD","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0e59889-74b5-4817-bf1d-9bd0c3147b04_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25113787","allele":{"id":"https://genegraph.clinicalgenome.org/r/3774afbf-485d-4b9c-883d-64bff23ba318","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_213720.3(CHCHD10):c.44G>T (p.Arg15Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA235291"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/17fceaac-876f-4d18-8727-b081db15c3c0","type":"EvidenceLine","dc:description":"absent in gnomAD","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/17fceaac-876f-4d18-8727-b081db15c3c0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25833818","allele":{"id":"https://genegraph.clinicalgenome.org/r/2751877d-3ad0-46df-9966-efdae9164e78","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_213720.3(CHCHD10):c.67C>A (p.Pro23Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA322574078"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/00f90c1e-7e1a-4ae2-856b-97b462aec6b4","type":"EvidenceLine","dc:description":"absent from gnomAD","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00f90c1e-7e1a-4ae2-856b-97b462aec6b4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26719383","allele":{"id":"https://genegraph.clinicalgenome.org/r/7ceaf73e-f0d4-4718-8577-e614dffa277c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_213720.3(CHCHD10):c.95C>A (p.Ala32Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA410916772"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/32215108-631e-400b-a454-4f56bc4d26cb","type":"EvidenceLine","dc:description":"gnomAD freq. above threshold. Listed as benign/likely benign in ClinVar\nTotal: 0.002585\nMax: 0.004415","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/32215108-631e-400b-a454-4f56bc4d26cb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25576308","allele":{"id":"https://genegraph.clinicalgenome.org/r/384d3228-9a6d-49b2-8202-bea8e66c4ad1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_213720.3(CHCHD10):c.100C>T (p.Pro34Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347295"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/82a79f3b-56c0-4a28-8013-1b5a0b09f72f","type":"EvidenceLine","dc:description":"gnomAD frequency 0.002. Listed as benign/likely benign in ClinVar","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82a79f3b-56c0-4a28-8013-1b5a0b09f72f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25726362","allele":{"id":"https://genegraph.clinicalgenome.org/r/384d3228-9a6d-49b2-8202-bea8e66c4ad1"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c9e608a7-e3d7-4542-a639-d93e35241f24","type":"EvidenceLine","dc:description":"gnomAD freq. greater than threshold\nTotal: 0.00001527\nMax: 0.00009999 (Latino/Admixed Am.)\n\nMethodology doesn't state other ALS-FTD genes were excluded","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c9e608a7-e3d7-4542-a639-d93e35241f24_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26152333","allele":{"id":"https://genegraph.clinicalgenome.org/r/14234838-bf15-4114-be0f-b8d076d962f6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_213720.3(CHCHD10):c.244C>T (p.Gln82Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10145285"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/67908548-99c5-4528-9876-e1cd771f9d86","type":"EvidenceLine","dc:description":"gnomAD freq. greater than threshold\nTotal: 0.00001703\nMax: 0.00004287 (European non Finnish)","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67908548-99c5-4528-9876-e1cd771f9d86_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25833818","allele":{"id":"https://genegraph.clinicalgenome.org/r/05a78e11-c0ac-40a7-839a-94cb5f449418","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_213720.3(CHCHD10):c.104C>A (p.Ala35Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA322574008"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/40ecae0b-b25f-40d8-a1c3-720185e6c1e8","type":"EvidenceLine","dc:description":"gnomAD freq > threshold.\nTotal: 0.000008209\nMax: 0.0001186 (east asian)","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/40ecae0b-b25f-40d8-a1c3-720185e6c1e8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27056076","allele":{"id":"https://genegraph.clinicalgenome.org/r/48ce683d-379a-4e09-b896-1a22a2af34de","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000022.11:g.23766283T>C (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA410915377"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/9c48b59b-d464-4f5a-965b-805df9dc2ef2","type":"EvidenceLine","dc:description":"High freq. in gnomAD\nTotal: 0.0002914\nMax: 0.003225 (AJ)","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9c48b59b-d464-4f5a-965b-805df9dc2ef2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25833818","allele":{"id":"https://genegraph.clinicalgenome.org/r/e728ce27-37c0-4892-b6e8-06d8192ec820","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_213720.3(CHCHD10):c.239C>T (p.Pro80Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347297"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/487b3261-1aa7-4a81-950b-07cae27c8d3d","type":"EvidenceLine","dc:description":"absent from gnomAD","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/487b3261-1aa7-4a81-950b-07cae27c8d3d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25261972","allele":{"id":"https://genegraph.clinicalgenome.org/r/3774afbf-485d-4b9c-883d-64bff23ba318"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/7ed37bfa-0f4f-4223-8d04-cc86822a3e51","type":"EvidenceLine","dc:description":"gnomAD frequency above threshold.\nTotal: 0.002585\nMax: 0.004415 (European Finnish)","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ed37bfa-0f4f-4223-8d04-cc86822a3e51_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25155093","allele":{"id":"https://genegraph.clinicalgenome.org/r/384d3228-9a6d-49b2-8202-bea8e66c4ad1"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c918ed80-4dd1-4012-8272-e83125352cbe","type":"EvidenceLine","dc:description":"gnomAD freq. greater than threshold:\nTotal: 0.000009278\nMax: 0.00002088 (European non Finnish)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c918ed80-4dd1-4012-8272-e83125352cbe_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"To address the pathogenicity of the novel Q108P variant in\nCHCHD10, they expressed the mutant protein in HeLa cells and\nprimary hippocampal neurons and noticed diffuse localization all\nover the cell compared to predominantly mitochondrial localization\nof the wild-type. These findings suggest that impaired mitochondrial\nimport is the main pathogenic mechanism for the CHCHD10 Q108P\nvariant","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/c918ed80-4dd1-4012-8272-e83125352cbe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29789341","allele":{"id":"https://genegraph.clinicalgenome.org/r/bf0096d3-2888-4a5d-8c24-b3d093b8ad3b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_213720.3(CHCHD10):c.323A>C (p.Gln108Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA322572683"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d05a8696-1358-4bfd-929d-c8445d5beac2","type":"EvidenceLine","dc:description":"absent from gnomAD","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d05a8696-1358-4bfd-929d-c8445d5beac2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26719383","allele":{"id":"https://genegraph.clinicalgenome.org/r/7fc68a63-da93-4865-a4bf-f64a125860c7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_213720.3(CHCHD10):c.170T>A (p.Val57Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA410916349"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4b8bb0b6-d40d-47ce-8052-9462f65a26d2","type":"EvidenceLine","dc:description":"gnomAD freq. 0.002. Listed as benign/likely benign in ClinVar","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4b8bb0b6-d40d-47ce-8052-9462f65a26d2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25726362","allele":{"id":"https://genegraph.clinicalgenome.org/r/384d3228-9a6d-49b2-8202-bea8e66c4ad1"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/825190a0-4f9b-4a5c-88c2-c88a2310bf2f","type":"EvidenceLine","dc:description":"absent from gnomAD","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/825190a0-4f9b-4a5c-88c2-c88a2310bf2f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Overexpression of a CHCHD10 mutant allele in HeLa cells led to fragmentation of the mitochondrial network and\nultrastructural major abnormalities including loss, disorganization and dilatation of cristae.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/825190a0-4f9b-4a5c-88c2-c88a2310bf2f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24934289","allele":{"id":"https://genegraph.clinicalgenome.org/r/de9ef273-9f5d-4032-9b64-220c86564331","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_213720.3(CHCHD10):c.176C>T (p.Ser59Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA163486"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/82d4f874-c965-4855-89c4-3d5952457b59","type":"EvidenceLine","dc:description":"High freq. in gnomAD\nTotal: 0.0002914\nMax: 0.003225 (AJ)","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82d4f874-c965-4855-89c4-3d5952457b59_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25833818","allele":{"id":"https://genegraph.clinicalgenome.org/r/e728ce27-37c0-4892-b6e8-06d8192ec820"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c1c2719b-2202-445c-8f08-4f92295721f1","type":"EvidenceLine","dc:description":"gnomAD freq. 0.002. Listed as benign/likely benign in ClinVar.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c1c2719b-2202-445c-8f08-4f92295721f1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25726362","allele":{"id":"https://genegraph.clinicalgenome.org/r/384d3228-9a6d-49b2-8202-bea8e66c4ad1"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/cde118ae-fd26-4ca2-8981-7fa767b695f9","type":"EvidenceLine","dc:description":"absent from gnomAD. No functional evidence added.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cde118ae-fd26-4ca2-8981-7fa767b695f9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24934289","allele":{"id":"https://genegraph.clinicalgenome.org/r/de9ef273-9f5d-4032-9b64-220c86564331"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/27cd418a-ea44-460a-bc85-fee35a06ada9","type":"EvidenceLine","dc:description":"absent from gnomAD","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/27cd418a-ea44-460a-bc85-fee35a06ada9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26719383","allele":{"id":"https://genegraph.clinicalgenome.org/r/92036433-5655-4bd3-920d-a72a182cb473","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_213720.3(CHCHD10):c.68C>T (p.Pro23Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA410916934"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/00466c3b-20cc-4015-8655-c89ea5d8d3c3","type":"EvidenceLine","dc:description":"gnomAD freq. > threshold.\nTotal: 0.00004720\nMax: 0.0002959 (African American)\n\nPatient w/ homozygous mutation","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00466c3b-20cc-4015-8655-c89ea5d8d3c3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26719383","allele":{"id":"https://genegraph.clinicalgenome.org/r/2886e2a4-d347-42f7-869f-772f742d04d2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_213720.3(CHCHD10):c.67C>T (p.Pro23Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA410916937"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e34fa1b1-615b-46bb-ab09-1befe901c876","type":"EvidenceLine","dc:description":"gnomAD freq. slightly above threshold:\nTotal: 0.000006776\nMax: 0.00009662 (African American)\n\nMethodology doesn't state that other ALS genes were excluded","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e34fa1b1-615b-46bb-ab09-1befe901c876_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26152333","allele":{"id":"https://genegraph.clinicalgenome.org/r/1f218cfd-237f-4d80-b19f-6005c912cc6c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_213720.3(CHCHD10):c.34C>T (p.Pro12Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10145330"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/a3a328ce-96be-481e-b337-c63a9de38abd","type":"EvidenceLine","dc:description":"gnomad > threshold.\nTotal: 0.0001945\nMax: 0.0007186 (South Asian)","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a3a328ce-96be-481e-b337-c63a9de38abd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27056076","allele":{"id":"https://genegraph.clinicalgenome.org/r/3b0d315d-07ca-4f89-823c-fef8131ffdd1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_213720.3(CHCHD10):c.285G>C (p.Gln95His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA410915096"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/61d2237b-43d1-4637-a1ec-c6f7a014850c","type":"EvidenceLine","dc:description":"Variant absent from gnomAD","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/61d2237b-43d1-4637-a1ec-c6f7a014850c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25113787","allele":{"id":"https://genegraph.clinicalgenome.org/r/3774afbf-485d-4b9c-883d-64bff23ba318"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d154f67a-25ce-40d3-9de3-1f001753843a_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/24ddca32-2135-4962-9c70-705917549167_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25113787","rdfs:label":"C","family":{"id":"https://genegraph.clinicalgenome.org/r/24ddca32-2135-4962-9c70-705917549167","type":"Family","rdfs:label":"C","member":{"id":"https://genegraph.clinicalgenome.org/r/f2fc9be2-bce7-4714-a91d-7ceb5b5cd8ff","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25113787","rdfs:label":"III-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/9a863c50-5514-4d37-aa97-fe456045601a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_213720.3(CHCHD10):c.197G>T (p.Gly66Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA346133"}},"firstTestingMethod":"Exome sequencing","previousTesting":true,"previousTestingDescription":"C9orf72 and SOD1","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/4ce5ce9d-2199-48a9-b63f-799f02b68b54_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25113787","allele":{"id":"https://genegraph.clinicalgenome.org/r/9a863c50-5514-4d37-aa97-fe456045601a"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"phenotypePositiveAllelePositive":1,"phenotypes":"obo:HP_0007354","proband":{"id":"https://genegraph.clinicalgenome.org/r/f2fc9be2-bce7-4714-a91d-7ceb5b5cd8ff"}},{"id":"https://genegraph.clinicalgenome.org/r/8ecfa71c-c85e-46ba-b799-cf2013b92e94_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24934289","rdfs:label":"Spain","family":{"id":"https://genegraph.clinicalgenome.org/r/8ecfa71c-c85e-46ba-b799-cf2013b92e94","type":"Family","rdfs:label":"Spain","member":{"id":"https://genegraph.clinicalgenome.org/r/0ff8527d-2c1f-40e5-87bf-f2baa35dda0b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24934289","rdfs:label":"SP-50","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":57,"allele":{"id":"https://genegraph.clinicalgenome.org/r/de9ef273-9f5d-4032-9b64-220c86564331"},"firstTestingMethod":"Exome sequencing","previousTesting":true,"previousTestingDescription":"C9orf72 and other candidate genes (TARDBP, FUS/TLS,\nSOD1, VCP, CHMP2B, ANG, SQSTM1, UBQLN2, PFN1).","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/cde118ae-fd26-4ca2-8981-7fa767b695f9_variant_evidence_item"}}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/0ff8527d-2c1f-40e5-87bf-f2baa35dda0b"}},{"id":"https://genegraph.clinicalgenome.org/r/09ad3f12-fcc6-48ef-bebd-26b9cfb72151_proband_segregation","type":"FamilyCosegregation","dc:description":"Does not demonstrate high penetrance.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25113787","rdfs:label":"A","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/09ad3f12-fcc6-48ef-bebd-26b9cfb72151","type":"Family","rdfs:label":"A","member":{"id":"https://genegraph.clinicalgenome.org/r/f73a960c-cfeb-4f7f-9a0f-38a1fa5e70f1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25113787","rdfs:label":"IV-3","allele":{"id":"https://genegraph.clinicalgenome.org/r/3774afbf-485d-4b9c-883d-64bff23ba318"},"detectionMethod":"Sanger sequencing of DNA from further family members in addition to the index patient","firstTestingMethod":"Exome sequencing","phenotypes":"obo:HP_0007354","previousTesting":true,"previousTestingDescription":"Both a repeat expansion in C9orf72 and mutations in SOD1 had been excluded","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e0e59889-74b5-4817-bf1d-9bd0c3147b04_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":3,"phenotypes":"obo:HP_0007354","proband":{"id":"https://genegraph.clinicalgenome.org/r/f73a960c-cfeb-4f7f-9a0f-38a1fa5e70f1"}},{"id":"https://genegraph.clinicalgenome.org/r/353f1bc8-2af7-48c4-a9aa-8e9e50b8709b_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25261972","rdfs:label":"USALS#5","family":{"id":"https://genegraph.clinicalgenome.org/r/353f1bc8-2af7-48c4-a9aa-8e9e50b8709b","type":"Family","rdfs:label":"USALS#5","member":{"id":"https://genegraph.clinicalgenome.org/r/a4a494df-6c4f-48c9-aebe-d7be1f76785c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25261972","rdfs:label":"USAALS#5-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/3774afbf-485d-4b9c-883d-64bff23ba318"},"firstTestingMethod":"Exome sequencing","previousTestingDescription":"C9orf72, SOD1, TARDBP, FUS, VCP, PFN1, UBQLN1, MATR3, SQSTM1, OPTN, and HNPNPA2B","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/487b3261-1aa7-4a81-950b-07cae27c8d3d_variant_evidence_item"}}},"phenotypePositiveAllelePositive":4,"phenotypes":"obo:HP_0007354","proband":{"id":"https://genegraph.clinicalgenome.org/r/a4a494df-6c4f-48c9-aebe-d7be1f76785c"}},{"id":"https://genegraph.clinicalgenome.org/r/fe632e81-aad4-40b2-8a92-128f9a5401e6_proband_segregation","type":"FamilyCosegregation","dc:description":"For mutation validation and segregation analysis, a part\nof CHCHD10 (NM_213720.1) spanning the mutation site in exon\n2 was amplified with the following primers: 5’-TCGGGCCAGCC\nGGGGCTC-3’ (forward); and 5’-GGAAGCCTGCCTCTAAGTGA-3’\n(reverse). Purification and sequencing of PCR products were performed.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24934289","rdfs:label":"French","estimatedLodScore":4.21,"family":{"id":"https://genegraph.clinicalgenome.org/r/fe632e81-aad4-40b2-8a92-128f9a5401e6","type":"Family","rdfs:label":"French","member":{"id":"https://genegraph.clinicalgenome.org/r/bed4b31c-04f7-4745-8621-cadf2174c5b6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24934289","rdfs:label":"IV-6","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":50,"allele":{"id":"https://genegraph.clinicalgenome.org/r/de9ef273-9f5d-4032-9b64-220c86564331"},"detectionMethod":"They sequenced the exome of Patients IV-11 and V-10. The procedure yielded 9.8 and\n12.4 Gb of mappable sequence and after alignment to the hg19\nreference genome. From the 62 252 and 63 036 identified single nucleotide polymorphisms in Patients IV-11 and V-10, respectively, the pathogenic variant was identified by the following scheme:\n\n (i) selection of heterozygous variants shared by the two patients; \n(ii) exclusion of polymorphic variants present in dbSNP132, EVS (Exome Variant Server), HapMap, 1000 Genome databases and in-house control exomes\n(iii) segregation analysis within the family. This filtering led us to identify a single heterozygous missense mutation (c.176C4T; p.Ser59Leu) in exon 2 of CHCHD10 that was present in the eight patients tested and was absent in two healthy individuals (Subjects IV-14 and IV-16) with normal neurological examination at 79 and 69 years\n","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Ataxia, muscle biopsy showed ragged-red fibers, cytochrome C oxidase (COX)-negative fibers, and mitochondrial DNA deletions","phenotypes":["obo:HP_0001324","obo:HP_0000727","obo:HP_0007354"],"previousTesting":true,"previousTestingDescription":"Analysis of genes involved in multiple mitochondrial DNA deletions\nwith a compatible phenotype (POLG, SLC25A4, C10orf2) revealed\nno mutation. ","secondTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/825190a0-4f9b-4a5c-88c2-c88a2310bf2f_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Ataxia, muscle biopsy showed ragged-red fibers, cytochrome C oxidase (COX)-negative fibers, and mitochondrial DNA deletions","phenotypePositiveAllelePositive":15,"phenotypes":["obo:HP_0007354","obo:HP_0001324","obo:HP_0000727"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/bed4b31c-04f7-4745-8621-cadf2174c5b6"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/b120aa58-711c-4efc-8ad1-2cdb373282df_proband_segregation","type":"FamilyCosegregation","dc:description":"Other familial reports of this variant show incomplete penetrance","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25681414","rdfs:label":"German Kindred","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/b120aa58-711c-4efc-8ad1-2cdb373282df","type":"Family","rdfs:label":"German Kindred","member":{"id":"https://genegraph.clinicalgenome.org/r/681b248f-6d9b-4369-98d0-cf4b9cf40e1f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25681414","rdfs:label":"III.1","allele":{"id":"https://genegraph.clinicalgenome.org/r/3774afbf-485d-4b9c-883d-64bff23ba318"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"ALS","previousTesting":true,"previousTestingDescription":"Excluded C9orf72 and mutations in 25 other known ALS genes","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e05768ba-7a98-4b6b-8110-ab99cb301297_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25681414","allele":{"id":"https://genegraph.clinicalgenome.org/r/3774afbf-485d-4b9c-883d-64bff23ba318"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"ALS","phenotypePositiveAllelePositive":7,"proband":{"id":"https://genegraph.clinicalgenome.org/r/681b248f-6d9b-4369-98d0-cf4b9cf40e1f"}},{"id":"https://genegraph.clinicalgenome.org/r/0d442f0b-fd50-45a2-8b37-0e49f4b57778_proband_segregation","type":"FamilyCosegregation","dc:description":"Several unaffected individuals with genotype. Does not demonstrate high penetrance. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25113787","rdfs:label":"B","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/0d442f0b-fd50-45a2-8b37-0e49f4b57778","type":"Family","rdfs:label":"B","member":{"id":"https://genegraph.clinicalgenome.org/r/7ef90b0b-eac1-4c47-8f7a-4f3bffdcf78a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25113787","rdfs:label":"III-10","allele":{"id":"https://genegraph.clinicalgenome.org/r/3774afbf-485d-4b9c-883d-64bff23ba318"},"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/61d2237b-43d1-4637-a1ec-c6f7a014850c_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/7ef90b0b-eac1-4c47-8f7a-4f3bffdcf78a"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/183b09fe-1456-4fe4-8912-4446401a9ef3","type":"EvidenceLine","dc:description":"absent from gnomAD","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/183b09fe-1456-4fe4-8912-4446401a9ef3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25261972","allele":{"id":"https://genegraph.clinicalgenome.org/r/3774afbf-485d-4b9c-883d-64bff23ba318"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f1db7369-d78a-4d03-8bb9-3400a231f695","type":"EvidenceLine","dc:description":"absent from gnomAD","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f1db7369-d78a-4d03-8bb9-3400a231f695_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26719383","allele":{"id":"https://genegraph.clinicalgenome.org/r/c008333b-d08b-44e5-86db-5adad0cdb2c9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_213720.3(CHCHD10):c.64C>T (p.His22Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA410916957"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/28a69877-6236-4de7-964c-85499e7597f0","type":"EvidenceLine","dc:description":"gnomAD frequency above threshold.\nTotal: 0.0002914\nMax: 0.003225 (AJ)","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/28a69877-6236-4de7-964c-85499e7597f0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25576308","allele":{"id":"https://genegraph.clinicalgenome.org/r/e728ce27-37c0-4892-b6e8-06d8192ec820"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e05768ba-7a98-4b6b-8110-ab99cb301297","type":"EvidenceLine","dc:description":"Variant absent from gnomAD","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e05768ba-7a98-4b6b-8110-ab99cb301297_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a8ecccfc-ecf2-45b6-84c7-be50cab361d0","type":"EvidenceLine","dc:description":"absent from gnomAD","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a8ecccfc-ecf2-45b6-84c7-be50cab361d0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25261972","allele":{"id":"https://genegraph.clinicalgenome.org/r/3774afbf-485d-4b9c-883d-64bff23ba318"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a932baf6-971f-49b6-95dd-c4d21e8eaa13","type":"EvidenceLine","dc:description":"gnomAD frequency above threshold\nTotal: 0.0002914\nMax: 0.003225 (Ashkenazi Jewish) ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a932baf6-971f-49b6-95dd-c4d21e8eaa13_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25576308","allele":{"id":"https://genegraph.clinicalgenome.org/r/e728ce27-37c0-4892-b6e8-06d8192ec820"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e4facd31-1088-4a48-823b-0b27d2fc6ba4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e4facd31-1088-4a48-823b-0b27d2fc6ba4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 29121267 shows p.R15L CHCHD10 variant in this patient's fibroblasts destabilizes the protein, leading to a defect in the assembly of Complex I, impaired cellular respiration, mitochondrial hyperfusion, an increase in the steady-state level of CHCHD2, and a severe proliferation defect on galactose","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e4facd31-1088-4a48-823b-0b27d2fc6ba4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25833818","allele":{"id":"https://genegraph.clinicalgenome.org/r/3774afbf-485d-4b9c-883d-64bff23ba318"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a3623924-8a8e-4301-bca3-6a5280dade33","type":"EvidenceLine","dc:description":"gnomAD frequency above threshold. \nTotal: 0.002585\nMax: 0.004415 (European Finnish)\n\nListed as benign/likely benign in ClinVar","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a3623924-8a8e-4301-bca3-6a5280dade33_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25155093","allele":{"id":"https://genegraph.clinicalgenome.org/r/384d3228-9a6d-49b2-8202-bea8e66c4ad1"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/4ce5ce9d-2199-48a9-b63f-799f02b68b54","type":"EvidenceLine","dc:description":"gnomAD frequency greater than threshold\nTotal: 0.00001598\nMax: European","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4ce5ce9d-2199-48a9-b63f-799f02b68b54_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":3.2},{"id":"https://genegraph.clinicalgenome.org/r/d154f67a-25ce-40d3-9de3-1f001753843a_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d154f67a-25ce-40d3-9de3-1f001753843a_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3f265251-36cc-4e4c-83d8-15609a083bd8","type":"EvidenceLine","dc:description":"Ortholog to CHCHD10 used with 41% identity in a non-mammalian model system. While decreased locomotion and decreased survival are seen with ALS, this does is not specific to the disease. The C. elegans ortholog shares 41% amino acid identity with CHCHD10 and\nCHCHD2 therefore a phenotype arising due to KD or KO of the ortholog cannot be attributed to loss of either CHCHD10 or CHCHD2 specifically, due to their homology","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b83ba12-df4a-4de8-9f1b-9905837d0dca","type":"Finding","dc:description":"Abnormal locomotion and decreased lifespan are consistent with motor neuron disease","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28585542","rdfs:label":"C. Elegans","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/151f3095-680a-4e58-8c0d-736c07a77e0d","type":"EvidenceLine","dc:description":"Lack of difference in motor behavior until late stages. Early death believed to be cardiopulmonary related. No clear evidence of motor neuron disease. CNS pathology (axonal swelling) does not result in a loss of motor neurons that give rise to peripheral motor axons. This paper is just suggesting a contribution of CNS, skeletal muscle, and cardiac pathology to CHCHD10 p.R15L-ALS pathogenesis.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b9bb293d-fe10-4d64-8e51-8943ef35f843","type":"Finding","dc:description":"Early death and abnormal protein accumulation is seen in ALS. Lack of difference in motor behavior until end of life may be due to lack of clinical manifestation of a pathology until later age.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33659869","rdfs:label":"Transgenic Mouse R15L","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/38070745-08df-4a2f-b370-ff69bffb0127","type":"EvidenceLine","dc:description":"Not a strong model system. Ortholog created. Difficult to distinguish CHCHD10 and CHCHD2.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/78301c7a-5739-4267-8742-f44f7ad28ebb","type":"Finding","dc:description":"Loss of motor neurons is characteristic for ALS","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33772006","rdfs:label":"Drosophila","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/47bf2138-1d3d-4d21-91f1-bcb3308b4d59","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae6bd9d1-8a5b-402d-916f-3d12a3691acb","type":"Finding","dc:description":"This phenotype aligns with the neurodegenerative disease reported in the large family with a S59L mutation (S55L in the mouse model)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30877432","rdfs:label":"Mouse KI","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d154f67a-25ce-40d3-9de3-1f001753843a_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0755dfa7-c70d-449d-806c-2a0ae0c53d71","type":"EvidenceLine","dc:description":"Adding as functional evidence to genetic evidence","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9ba7d740-09ea-450c-b317-83c025ff9942","type":"FunctionalAlteration","dc:description":"Immunoblot analysis on fibroblasts from an\nALS patient, heterozygous for the c.44G>T (p.R15L) CHCHD10 variant. CHCHD10 was reduced to 57% of control levels in patient fibroblasts, whereas the level of its paralogue, CHCHD2, was\nincreased 2.5-fold (Fig. 1A).\n\nImmunofluorescence analysis revealed a striking mitochondrial\nhyperfusion phenotype in patient cells and in control fibroblasts\nin which CHCHD10 was depleted by siRNA\n\nBasal mitochondrial respiration of patient\ncell lines was reduced by 46 6 12% (P <0.05) compared with controls.  overexpression of\nwild-type CHCHD10 in patient fibroblasts rescued the respiration defect\n\nTo interrogate mitochondrial respiratory function, we grew cells\nin medium containing a non-fermentable carbon source (in\nwhich glucose is replaced by galactose), forcing them to rely\nalmost entirely on OXPHOS for ATP production. In general, cells\nwith OXPHOS deficiencies grow more slowly than control cells\nin galactose medium or, if the deficiency is severe, undergo\napoptosis. About 20% of the patient fibroblasts died within the\nfirst 24 h in galactose, and while the remaining cells stayed\nattached to the plate","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29121267","rdfs:label":"R15L Fibroblasts"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/7c6bdff1-27ae-483e-9789-c804a458fef6","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7040a722-c7d4-4351-8bbb-097b7728565b","type":"FunctionalAlteration","dc:description":"Examined insoluble TDP-43 levels after CHCHD10WT and\nCHCHD10S59L transfection. Strikingly, CHCHD10S59L expression\nincreased insoluble TDP-43, whereas CHCHD10WT expression\ndecreased insoluble TDP-43 (Fig. 4b). Co-expression of\nCHCHD10WT with CHCHD10S59L suppressed CHCHD10S59Linduced insoluble TDP-43 ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33772006","rdfs:label":"TDP43 solubility and mitochondrial translocation"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d154f67a-25ce-40d3-9de3-1f001753843a_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eaf4aa47-22be-431d-97d9-197d264a78a6","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/68e5af7e-84a5-44ea-aabe-f58ff13c2205","type":"Finding","dc:description":"Wild-type CHCHD10 ameliorates and FTD/ALS CHCHD10 mutations potentiate TDP-43-induced apoptosis and synaptic impairment","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28585542","rdfs:label":"Mutant CHCHD10 on TDP43 apoptosis and synaptic damange","demonstrates":{"id":"obo:MI_0208"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ac8ab196-6e4e-4ad9-b9f4-242bd53a7b7c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e288c18-61d8-4908-8ba4-401c6b2a0f24","type":"Finding","dc:description":"TDP-43 forms a complex with CHCHD10 and promotes its nuclear localization\nCHCHD10 depletion and FTD/ALS CHCHD10 mutations induce cytoplasmic TDP-43 mislocalization\nFTD/ALS CHCHD10 mutations induce TDP-43 mislocalization frequently with mitochondria\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28585542","rdfs:label":"TDP43 Interacts w/ CHCHD10 ","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/693b97f2-e591-4508-abfb-f503a9cf5da5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/318edd05-6966-4149-a8da-fcb9589db91b","type":"Finding","dc:description":"Disruption of CHCHD10-regulated OPA1-mitofilin complex contributes to mitochondrial abnormalities in FTLD-TDP. CHCHD10 restoration could ameliorate mitochondrial dysfunction in FTLD-TDP","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32369233","rdfs:label":"CHCHD10 TDP43 mito dysfunction","demonstrates":{"id":"obo:MI_0208"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c3cf5b6d-47a0-423f-916d-44c9ea0ff2ad","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/beae7d0b-8f62-483e-97bb-e6be4a7d0375","type":"Finding","dc:description":"The CHCHD10 mutated ALS case showed a different pattern\nof CHCHD10 labeling; in addition to the strong neuronal\ncytoplasmic and axonal staining seen in the other cases, there\nwere also numerous aggregates of CHCHD10 within the\nanterior horns, slightly more abundant at cervical levels\n(figure 3, E–G, figure e-1, A–C, links.lww.com/NXG/A218).\nThese aggregates had a dense central core and a surrounding\nhalo of CHCHD10 immunopositivity (figure 3, H and I), and\nthey did not contain CHCHD2. Also present were rare\ncorkscrew-shaped CHCHD10 immunopositive inclusions\nwithin all levels of the anterior horn (figure 3, F and J). The\nfrontal cortex of the CHCHD10 mutated case showed predominantly strong neuronal cytoplasmic and axonal labeling\nwith CHCHD10, but CHCHD10 aggregates and corkscrewshaped inclusions were also present focally in the superficial\ncortical layers (figure e-1, D–F).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32042922","rdfs:label":"Postmortem R15L","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.5}],"evidenceStrength":"Moderate","sequence":5521,"specifiedBy":"GeneValidityCriteria9","strengthScore":7.7,"subject":{"id":"https://genegraph.clinicalgenome.org/r/V8hSxX3IgVU","type":"GeneValidityProposition","disease":"obo:MONDO_0014395","gene":"hgnc:15559","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_d154f67a-25ce-40d3-9de3-1f001753843a-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}